Carl Zeiss Meditec - CZMWY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$50.07
▼ -1.22 (-2.38%)

This chart shows the closing price for CZMWY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Carl Zeiss Meditec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CZMWY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CZMWY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Carl Zeiss Meditec in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $50.07.

This chart shows the closing price for CZMWY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Carl Zeiss Meditec. This rating has held steady since July 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/17/2023UBS GroupDowngradeBuy ➝ Neutral
8/7/2023Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
2/6/2023Berenberg BankDowngradeBuy ➝ Hold
10/31/2022Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy€156.00 ➝ €167.00
10/5/2022Berenberg BankUpgradeHold ➝ Buy
6/27/2022Deutsche Bank AktiengesellschaftLower Target€210.00 ➝ €156.00
2/7/2022AlphaValueUpgradeReduce
12/16/2021HSBCUpgradeReduce ➝ Hold
11/1/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
8/10/2021HSBCDowngradeHold ➝ Reduce
7/21/2021Berenberg BankReiterated RatingHold
5/27/2021Berenberg BankReiterated RatingHold
4/20/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/16/2021Kepler Capital MarketsUpgradeReduce ➝ Hold
2/16/2021CommerzbankUpgradeReduce ➝ Hold
2/9/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
1/22/2021DZ BankUpgradeSell ➝ Hold
1/20/2021Berenberg BankReiterated RatingHold
1/20/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
11/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/23/2020UBS GroupDowngradeBuy ➝ Neutral
7/17/2020Berenberg BankReiterated RatingHold
7/16/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
(Data available from 12/18/2019 forward)

News Sentiment Rating

0.66 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2024

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Carl Zeiss Meditec logo
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Read More

Today's Range

Now: $50.07
Low: $49.80
High: $50.44

50 Day Range

MA: $62.83
Low: $50.07
High: $74.03

52 Week Range

Now: $50.07
Low: $49.80
High: $134.60

Volume

25,478 shs

Average Volume

5,061 shs

Market Capitalization

N/A

P/E Ratio

54.42

Dividend Yield

1.36%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Carl Zeiss Meditec?

The following Wall Street research analysts have issued research reports on Carl Zeiss Meditec in the last twelve months:
View the latest analyst ratings for CZMWY.

What is the current price target for Carl Zeiss Meditec?

0 Wall Street analysts have set twelve-month price targets for Carl Zeiss Meditec in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Carl Zeiss Meditec in the next year.
View the latest price targets for CZMWY.

What is the current consensus analyst rating for Carl Zeiss Meditec?

Carl Zeiss Meditec currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CZMWY.

What other companies compete with Carl Zeiss Meditec?

How do I contact Carl Zeiss Meditec's investor relations team?

Carl Zeiss Meditec's physical mailing address is Goeschwitzer Strasse 51-52, Jena, Thueringen 07745. The company's listed phone number is 493641220115. The official website for Carl Zeiss Meditec is www.zeiss.com. Learn More about contacing Carl Zeiss Meditec investor relations.